{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T02:45:46Z","timestamp":1780713946852,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,2,10]],"date-time":"2012-02-10T00:00:00Z","timestamp":1328832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,2,10]],"date-time":"2012-02-10T00:00:00Z","timestamp":1328832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s10067-012-1952-1","type":"journal-article","created":{"date-parts":[[2012,2,9]],"date-time":"2012-02-09T18:36:20Z","timestamp":1328812580000},"page":"853-860","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Correlation of serum CX3CL1 level with disease activity in adult-onset Still's disease and significant involvement in hemophagocytic syndrome"],"prefix":"10.1007","volume":"31","author":[{"given":"Tsuyoshi","family":"Kasama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Furuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Yanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Yajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Miwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,10]]},"reference":[{"key":"1952_CR1","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","volume":"70","author":"J Pouchot","year":"1991","unstructured":"Pouchot J, Sampalis JS, Beaudet F, Carette S, Decary F, Salusinsky-Sternbach M et al (1991) Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine 70:118\u2013136","journal-title":"Medicine"},{"key":"1952_CR2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/ncprheum0510","volume":"3","author":"P Efthimiou","year":"2007","unstructured":"Efthimiou P, Kontzias A, Ward CM, Ogden NS (2007) Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy? Nat Clin Pract Rheumatol 3:328\u2013335","journal-title":"Nat Clin Pract Rheumatol"},{"key":"1952_CR3","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/ard.51.5.683","volume":"51","author":"M Schwarz-Eywill","year":"1992","unstructured":"Schwarz-Eywill M, Heilig B, Bauer H, Breitbart A, Pezzutto A (1992) Evaluation of serum ferritin as a marker for adult Still's disease activity. Ann Rheum Dis 51:683\u2013685","journal-title":"Ann Rheum Dis"},{"key":"1952_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/07388550903187418","volume":"30","author":"M Sharma","year":"2010","unstructured":"Sharma M (2010) Chemokines and their receptors: orchestrating a fine balance between health and disease. Crit Rev Biotechnol 30:1\u201322","journal-title":"Crit Rev Biotechnol"},{"key":"1952_CR5","first-page":"653","volume":"14","author":"MA Scheinberg","year":"1996","unstructured":"Scheinberg MA, Chapira E, Fernandes ML, Hubscher O (1996) Interleukin 6: a possible marker of disease activity in adult onset Still's disease. Clin Exp Rheumatol 14:653\u2013655","journal-title":"Clin Exp Rheumatol"},{"key":"1952_CR6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/1529-0131(200103)44:3<550::AID-ANR103>3.0.CO;2-5","volume":"44","author":"M Kawashima","year":"2001","unstructured":"Kawashima M, Yamamura M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M et al (2001) Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. Arthritis Rheum 44:550\u2013560","journal-title":"Arthritis Rheum"},{"key":"1952_CR7","first-page":"2422","volume":"30","author":"JH Choi","year":"2003","unstructured":"Choi JH, Suh CH, Lee YM, Suh YJ, Lee SK, Kim SS et al (2003) Serum cytokine profiles in patients with adult onset Still's disease. J Rheumatol 30:2422\u20132427","journal-title":"J Rheumatol"},{"key":"1952_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S et al (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48:124\u2013131","journal-title":"Pediatr Blood Cancer"},{"key":"1952_CR9","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/00002281-200309000-00011","volume":"15","author":"AA Grom","year":"2003","unstructured":"Grom AA (2003) Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities? Curr Opin Rheumatol 15:587\u2013590","journal-title":"Curr Opin Rheumatol"},{"key":"1952_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S1568-9972(03)00091-0","volume":"3","author":"C Larroche","year":"2004","unstructured":"Larroche C, Mouthon L (2004) Pathogenesis of hemophagocytic syndrome (HPS). Autoimmun Rev 3:69\u201375","journal-title":"Autoimmun Rev"},{"key":"1952_CR11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.7326\/0003-4819-114-5-387","volume":"114","author":"KF Wong","year":"1991","unstructured":"Wong KF, Hui PK, Chan JLC (1991) The acute lupus hemophagocytic syndrome. Ann Int Med 114:387\u2013390","journal-title":"Ann Int Med"},{"key":"1952_CR12","doi-asserted-by":"publisher","first-page":"607","DOI":"10.2169\/internalmedicine.33.607","volume":"33","author":"R Onishi","year":"1994","unstructured":"Onishi R, Namiuchi (1994) Hemophagocytic syndrome in a patient with rheumatoid arthritis. Intern Med 33:607\u2013611","journal-title":"Intern Med"},{"key":"1952_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s100670200022","volume":"21","author":"M Negishi","year":"2002","unstructured":"Negishi M, Kasama T, Iwabuchi H, Kanemitsu H, Ide H (2002) Autoimmune-associated hemophagocytic syndrome in a patient with rheumatoid arthritis. Clin Rheumatol 21:87\u201388","journal-title":"Clin Rheumatol"},{"key":"1952_CR14","first-page":"1838","volume":"35","author":"N Yajima","year":"2008","unstructured":"Yajima N, Wakabayashi K, Odai T, Isozaki T, Matsunawa M, Miwa Y et al (2008) Clinical features of hemophagocytic syndrome in patients with dermatomyositis. J Rheumatol 35:1838\u20131841","journal-title":"J Rheumatol"},{"key":"1952_CR15","first-page":"1425","volume":"19","author":"M Coffernils","year":"1992","unstructured":"Coffernils M, Soupart A, Pradier O, Feremans W, Neve P, Decaux G (1992) Hyperferritinemia in adult onset Still's disease and the hemophagocytic syndrome. J Rheumatol 19:1425\u20131427","journal-title":"J Rheumatol"},{"key":"1952_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/MD.0b013e3181caf100","volume":"89","author":"A Hot","year":"2010","unstructured":"Hot A, Toh ML, Coppere B, Perard L, Madoux MH, Mausservey C et al (2010) Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features and long-term outcome: a case-control study of 8 patients. Medicine 89:37\u201346","journal-title":"Medicine"},{"key":"1952_CR17","first-page":"424","volume":"19","author":"M Yamaguchi","year":"1992","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H et al (1992) Preliminary criteria for classification of adult Still's disease. J Rheumatol 19:424\u2013430","journal-title":"J Rheumatol"},{"key":"1952_CR18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/art.1780300209","volume":"30","author":"JJ Cush","year":"1987","unstructured":"Cush JJ, Medsger TA Jr, Christy WC, Herbert DC, Cooperstein LA (1987) Adult-onset Still's disease. Clinical course and outcome. Arthritis Rheum 30:186\u2013194","journal-title":"Arthritis Rheum"},{"key":"1952_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.autrev.2010.11.009","volume":"10","author":"M Zen","year":"2011","unstructured":"Zen M, Canova M, Campana C, Bettio S, Nalotto L, Rampudda M et al (2011) The kaleidoscope of glucorticoid effects on immune system. Autoimmun Rev 10:305\u2013310","journal-title":"Autoimmun Rev"},{"key":"1952_CR20","first-page":"396","volume":"25","author":"T Hoshino","year":"1998","unstructured":"Hoshino T, Ohta A, Yang D, Kawamoto M, Kikuchi M, Inoue Y et al (1998) Elevated serum interleukin 6, interferon-gamma, and tumor necrosis factor-alpha levels in patients with adult Still's disease. J Rheumatol 25:396\u2013398","journal-title":"J Rheumatol"},{"key":"1952_CR21","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1093\/rheumatology\/40.12.1398","volume":"40","author":"T Fujii","year":"2001","unstructured":"Fujii T, Nojima T, Yasuoka H, Satoh S, Nakamura K, Kuwana M et al (2001) Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease. Rheumatology 40:1398\u20131404","journal-title":"Rheumatology"},{"key":"1952_CR22","first-page":"2189","volume":"31","author":"DY Chen","year":"2004","unstructured":"Chen DY, Lan JL, Lin FJ, Hsieh TY (2004) Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease. J Rheumatol 31:2189\u20132198","journal-title":"J Rheumatol"},{"key":"1952_CR23","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1002\/1529-0131(200107)44:7<1568::AID-ART280>3.0.CO;2-1","volume":"44","author":"JH Ruth","year":"2001","unstructured":"Ruth JH, Volin MV, Haines GK 3rd, Woodruff DC, Katschke KJ Jr, Woods JM et al (2001) Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis. Arthritis Rheum 44:1568\u20131581","journal-title":"Arthritis Rheum"},{"key":"1952_CR24","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1002\/art.22208","volume":"54","author":"M Matsunawa","year":"2006","unstructured":"Matsunawa M, Isozaki T, Odai T, Yajima N, Takeuchi HT, Negishi M et al (2006) Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitis. Arthritis Rheum 54:3408\u20133416","journal-title":"Arthritis Rheum"},{"key":"1952_CR25","first-page":"72","volume":"27","author":"M Matsunawa","year":"2009","unstructured":"Matsunawa M, Odai T, Wakabayashi K, Isozaki T, Yajima N, Miwa Y et al (2009) Elevated serum levels of soluble CX3CL1 in patients with microscopic polyangiitis. Clin Exp Rheumatol 27:72\u201378","journal-title":"Clin Exp Rheumatol"},{"key":"1952_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.trsl.2009.08.009","volume":"155","author":"T Kasama","year":"2010","unstructured":"Kasama T, Wakabayashi K, Sato M, Takahashi R, Isozaki T (2010) Relevance of the CX3CL1\/fractalkine-CX3CR1 pathway in vasculitis and vasculopathy. Transl Res 155:20\u201326","journal-title":"Transl Res"},{"key":"1952_CR27","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.4049\/jimmunol.175.10.6987","volume":"175","author":"F Suzuki","year":"2005","unstructured":"Suzuki F, Nanki T, Imai T, Kikuchi H, Hirohata S, Kohsaka H et al (2005) Inhibition of CX3CL1 (fractalkine) improves experimental autoimmune myositis in SJL\/J mice. J Immunol 175:6987\u20136996","journal-title":"J Immunol"},{"key":"1952_CR28","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/rheumatology\/ken197","volume":"47","author":"G Murphy","year":"2008","unstructured":"Murphy G, Caplice N, Molloy M (2008) Fractalkine in rheumatoid arthritis: a review to date. Rheumatology 47:1446\u20131451","journal-title":"Rheumatology"},{"key":"1952_CR29","first-page":"1027","volume":"30","author":"O Lambotte","year":"2003","unstructured":"Lambotte O, Cacoub P, Costedoat N, Le Moel G, Amoura Z, Piette JC (2003) High ferritin and low glycosylated ferritin may also be a marker of excessive macrophage activation. J Rheumatol 30:1027\u20131028","journal-title":"J Rheumatol"},{"key":"1952_CR30","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1146\/annurev.immunol.19.1.423","volume":"19","author":"K Nakanishi","year":"2001","unstructured":"Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H (2001) Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 19:423\u2013474","journal-title":"Annu Rev Immunol"},{"key":"1952_CR31","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/jemt.1090","volume":"53","author":"K Kobayashi","year":"2001","unstructured":"Kobayashi K, Kaneda K, Kasama T (2001) Immunopathogenesis of delayed-type hypersensitivity. Microsc Res Tech 53:241\u2013245","journal-title":"Microsc Res Tech"},{"key":"1952_CR32","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1136\/ard.2003.013680","volume":"63","author":"DY Chen","year":"2004","unstructured":"Chen DY, Lan JL, Lin FJ, Hsieh TY, Wen MC (2004) Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease. Ann Rheum Dis 63:1300\u20131306","journal-title":"Ann Rheum Dis"},{"key":"1952_CR33","first-page":"807","volume":"6","author":"A Hildesheim","year":"1997","unstructured":"Hildesheim A, Schiffman MH, Tsukui T, Swanson CA, Lucci J 3rd, Scott DR et al (1997) Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease. Cancer Epidemiol Biomarkers Prev 6:807\u2013813","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1952_CR34","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1172\/JCI11517","volume":"107","author":"P Fraticelli","year":"2001","unstructured":"Fraticelli P, Sironi M, Bianchi G, D'Ambrosio D, Albanesi C, Stoppacciaro A et al (2001) Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest 107:1173\u20131181","journal-title":"J Clin Invest"},{"key":"1952_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10165-008-0116-2","volume":"19","author":"H Nakahara","year":"2009","unstructured":"Nakahara H, Mima T, Yoshio-Hoshino N, Matsushita M, Hashimoto J, Nishimoto N (2009) A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6\u00a0years. Mod Rheumatol 19:69\u201372","journal-title":"Mod Rheumatol"},{"key":"1952_CR36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ard.2008.088179","volume":"68","author":"M De Bandt","year":"2009","unstructured":"De Bandt M, Saint-Marcoux B (2009) Tocilizumab for multirefractory adult-onset Still's disease. Ann Rheum Dis 68:153\u2013154","journal-title":"Ann Rheum Dis"},{"key":"1952_CR37","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s10067-010-1553-9","volume":"29","author":"K Perdan-Pirkmajer","year":"2010","unstructured":"Perdan-Pirkmajer K, Praprotnik S, Tomsic M (2010) A case of refractory adult-onset Still's disease successfully controlled with tocilizumab and a review of the literature. Clin Rheumatol 29:1465\u20131467","journal-title":"Clin Rheumatol"},{"key":"1952_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.imbio.2004.04.001","volume":"209","author":"P Ancuta","year":"2004","unstructured":"Ancuta P, Moses A, Gabuzda D (2004) Transendothelial migration of CD16+ monocytes in response to fractalkine under constitutive and inflammatory conditions. Immunobiology 209:11\u201320","journal-title":"Immunobiology"},{"key":"1952_CR39","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.semarthrit.2006.07.001","volume":"36","author":"P Efthimiou","year":"2006","unstructured":"Efthimiou P, Georgy S (2006) Pathogenesis and management of adult-onset Still's disease. Semin Arthritis Rheum 36:144\u2013152","journal-title":"Semin Arthritis Rheum"},{"key":"1952_CR40","first-page":"230","volume":"132","author":"U Emmenegger","year":"2002","unstructured":"Emmenegger U, Reimers A, Frey U, Fux C, Bihl F, Semela D et al (2002) Reactive macrophage activation syndrome: a simple screening strategy and its potential in early treatment initiation. Swiss Med Wkly 132:230\u2013236","journal-title":"Swiss Med Wkly"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-012-1952-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-012-1952-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-012-1952-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-012-1952-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T16:16:35Z","timestamp":1659111395000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-012-1952-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,10]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["1952"],"URL":"https:\/\/doi.org\/10.1007\/s10067-012-1952-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,10]]},"assertion":[{"value":"24 September 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}